In summary, these data suggest that the Wnt5a antagonist Box5 could alleviate kidney injury in db/db mice and ameliorate the progression of DN via a mechanism independent of insulin sensitizing effects. The gene discussed is WNT5A; the disease is liver dysplastic nodule.